Predicting in vivo activity of combination therapies from in vitro drug pairs in diverse environments
Sarah C. Patterson, Adam Christopher Palmer · Cell Reports Medicine · 2022
New antibiotic combinations are needed to improve the treatment of tuberculosis. Larkins-Ford and colleagues share a framework that combines in vitro pairwise drug response data and machine learning to rationally prioritize combinations for clinical development. 1